Bill Miller Halozyme Therapeutics, Inc. Transaction History

Miller Value Partners, LLC

  • $177 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$13.9 - $21.83 $278,000 - $436,599
-20,000 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$13.33 - $18.66 $2 Million - $2.8 Million
-150,000 Reduced 88.24%
20,000 $293,000
Q3 2017

Nov 14, 2017
BUY
$11.76 - $17.4 $2 Million - $2.96 Million
170,000
170,000 $2.95 Million

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track Bill Miller's Portfolio

Track Bill Miller Portfolio

Follow Bill Miller (Miller Value Partners, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email